NSE
Dr. Lal Path Labs Ltd.LALPATHLAB
Dr Lal PathLabs is a leading diagnostics chain.
| Key products | Pathology and diagnostic testing services. |
|---|---|
| Geography | India (North-led). |
| Competitors | Metropolis, Agilus, Vijaya. |
AI-generated overview — verify before relying on it.
Net institutional flow
No institutional deals
Institutional buyers
0 in / 0 out
High-impact filings
0 · tilt Neutral
Next corporate action
Dividend - Rs 4 Per Share
ex 2026-06-25
| # | Company | Inst. flow ₹Cr | Deals | Hi-impact | Filing mom. | Buzz | News |
|---|---|---|---|---|---|---|---|
| 1 | LALPATHLABThis | — | — | — | — | — | — |
| 2 | CIPLA | — | — | — | — | +19 | 44 |
| 3 | DRREDDY | — | — | — | — | +20 | 46 |
| 4 | SUNPHARMA | — | — | — | — | +15 | 45 |
| 5 | TORNTPHARM | — | — | — | — | — | — |
| 6 | LUPIN | — | — | — | — | — | — |
| 7 | ZYDUSLIFE | — | — | 1 | +1 | — | — |
| 8 | APOLLOHOSP | — | — | 1 | — | — | — |
| 9 | AUROPHARMA | — | — | — | — | — | — |
Ranked by net institutional flow (buys − sells, ₹Cr). Filing momentum = bullish − bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.
- 2026-06-25ActionDividend - Rs 4 Per ShareDividend
- 2026-06-12FilingDr. Lal Path Labs Ltd. has informed the Exchange about General Updates- Update on Incorporation of Wholly OwneGeneral
- 2026-02-05ActionInterim Dividend - Rs 3.50 Per ShareDividend
- 2025-12-19ActionBonus 1:1Bonus
- 2025-11-07ActionInterim Dividend - Rs 7 Per ShareDividend
- 2025-10-20BlockSELL · ₹10.6 CrGOLDMAN SACHS (SINGAPORE) PTE - ODI
- 2025-10-20BlockBUY · ₹10.6 CrGOLDMAN SACHS BANK EUROPE SE - ODI
- 2025-08-06ActionInterim Dividend - Rs 6 Per ShareDividend
- 2025-06-06ActionDividend - Rs 6 Per ShareDividend
- 2025-02-05ActionInterim Dividend - Rs 6 Per ShareDividend
- 2025-01-06BulkSELL · ₹130.4 CrMULTI-MANAGER ICVC
- 2025-01-06NetDay net −₹130.4 Cr
- 2024-11-05ActionInterim Dividend - Rs 6 Per ShareDividend
Merged from deals, filings, corporate actions and news — newest first. Compact rolls each day up to net flow + counts. Scope with the range above.
Filings that matter
- 2GeneralNeutral
General Updates- Update on Incorporation of Wholly Owned Subsidiary Company
Source PDF →
3 deals · 2025-01-06 → 2025-10-20
| Date | Counterparty | Type | Side | Value |
|---|---|---|---|---|
| 2025-10-20 | GOLDMAN SACHS (SINGAPORE) PTE - ODI | HNI / other | SELL | ₹10.6 Cr |
| 2025-10-20 | GOLDMAN SACHS BANK EUROPE SE - ODI | HNI / other | BUY | ₹10.6 Cr |
| 2025-01-06 | MULTI-MANAGER ICVC | HNI / other | SELL | ₹130.4 Cr |
3 deals in the selected window — corporate actions are scoped to the same period. ~2 years of history available.
News & chatter on LALPATHLAB
RSS News
0No recent news.
Google News RSS — links open the source.
Investdesk
0No articles yet.
Our coverage.
No Reddit chatter.
r/ posts mentioning the company.
Twitter / X
0No posts.
Posts mentioning the company.